Zelira Therapeutics (ZLDAF, $0.49) was one of top quarterly gainers, jumping to $0.49 per share. A.I.dvisor analyzed 839 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.